de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons41925

Fonteijn,  Hubert M.
Neurobiology of Language Department, MPI for Psycholinguistics, Max Planck Society;
Centre for Medical Image Computing, University College London, Gower Street, WC1E 6BT, London, UK;
Department of Computer Science, University College London, Gower Street, WC1E 6BT, London, UK;

Locator
There are no locators available
Fulltext (public)

Fonteijn_et_al_2012_NeuroImage.pdf
(Publisher version), 2MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Fonteijn, H. M., Modat, M., Clarkson, M. J., Barnes, J., Lehmann, M., Hobbs, N. Z., et al. (2012). An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease. NeuroImage, 60, 1880-1889. doi:10.1016/j.neuroimage.2012.01.062.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000F-0FF6-E
Abstract
Understanding the progression of neurological diseases is vital for accurate and early diagnosis and treatment planning. We introduce a new characterization of disease progression, which describes the disease as a series of events, each comprising a significant change in patient state. We provide novel algorithms to learn the event ordering from heterogeneous measurements over a whole patient cohort and demonstrate using combined imaging and clinical data from familial-Alzheimer's and Huntington's disease cohorts. Results provide new detail in the progression pattern of these diseases, while confirming known features, and give unique insight into the variability of progression over the cohort. The key advantage of the new model and algorithms over previous progression models is that they do not require a priori division of the patients into clinical stages. The model and its formulation extend naturally to a wide range of other diseases and developmental processes and accommodate cross-sectional and longitudinal input data.